Jefferies Group LLC Adverum Biotechnologies, Inc. Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $142,650 - $291,736	-17,876 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$5.12 - $12.22 $91,525 - $218,444	17,876 New	17,876 $206,000
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $78,970 - $102,810	-14,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $54,385 - $118,455	14,900 New	14,900 $86,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $571M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.